State Street’s GALENA BIOPHARMA INC COM RXII Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2016
Q4
Sell
-2,882,645
Closed -$1.01M 3744
2016
Q3
$1.01M Buy
2,882,645
+128,675
+5% +$45.2K ﹤0.01% 3191
2016
Q2
$1.28M Buy
2,753,970
+352,324
+15% +$164K ﹤0.01% 3195
2016
Q1
$3.27M Buy
2,401,646
+40,524
+2% +$55.1K ﹤0.01% 2778
2015
Q4
$3.47M Buy
2,361,122
+199,243
+9% +$293K ﹤0.01% 2738
2015
Q3
$3.42M Buy
2,161,879
+124,107
+6% +$196K ﹤0.01% 2723
2015
Q2
$3.47M Buy
2,037,772
+263,724
+15% +$449K ﹤0.01% 2830
2015
Q1
$2.47M Buy
1,774,048
+1,231
+0.1% +$1.71K ﹤0.01% 2945
2014
Q4
$2.68M Buy
1,772,817
+46,252
+3% +$69.8K ﹤0.01% 2910
2014
Q3
$3.56M Buy
1,726,565
+83,482
+5% +$172K ﹤0.01% 2723
2014
Q2
$5.03M Sell
1,643,083
-5,560,762
-77% -$17M ﹤0.01% 2587
2014
Q1
$18M Buy
7,203,845
+2,191,609
+44% +$5.48M ﹤0.01% 1864
2013
Q4
$24.9M Buy
5,012,236
+4,121,977
+463% +$20.4M ﹤0.01% 1593
2013
Q3
$2.02M Buy
890,259
+51,025
+6% +$116K ﹤0.01% 3034
2013
Q2
$1.86M Buy
+839,234
New +$1.86M ﹤0.01% 3010